scispace - formally typeset
C

Carsten Behrens

Researcher at Novo Nordisk

Publications -  58
Citations -  4495

Carsten Behrens is an academic researcher from Novo Nordisk. The author has contributed to research in topics: Glucagon receptor & Glucagon. The author has an hindex of 21, co-authored 58 publications receiving 4305 citations. Previous affiliations of Carsten Behrens include University of Copenhagen & Millipore Corporation.

Papers
More filters
Journal ArticleDOI

PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rules

TL;DR: It is reported here that PNA containing all four natural nucleobases hybridizes to complementary oligonucleotides obeying the Watson–Crick base-pairing rules, and thus is a true DNA mimic in terms of base- Pair recognition.
Journal ArticleDOI

Synthesis of Peptide Nucleic Acid Monomers Containing the Four Natural Nucleobases: Thymine, Cytosine, Adenine, and Guanine and Their Oligomerization

TL;DR: The preparation of mixed-sequence PNAs (PNAs containing the four natural nucleobases; thymine, cytosine, adenine, and guanine) is described, essentially following standard solid phase peptide synthesis protocols.
Patent

Glucagon antagonists/inverse agonists

TL;DR: In this paper, a novel class of compounds, which act to antagonize the action of the glucagon hormone on the receptor, were proposed for the treatment and prevention of any diseases and disorders, wherein a glucagon antagonistic action is beneficial, such as hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism and obesity.
Journal ArticleDOI

Engineered CHO cells for production of diverse, homogeneous glycoproteins.

TL;DR: An engineering approach will aid the production of glycoproteins with improved properties and therapeutic potential by constructing a design matrix that facilitates the generation of desired glycosylation, such as human-like α2,6-linked sialic acid capping.